STOCK TITAN

Prenetics CFO Stephen Hoi Chun Lo to leave Dec. 30

Brian Rosin's appointment as principal financial and accounting officer is conditional on board approval and execution of a formal agreement.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Prenetics Global Ltd announced that Stephen Hoi Chun Lo tendered his resignation as chief financial officer on October 30, 2026, effective December 30, 2026. He will remain CFO through that date and then support the company in an advisory capacity.

The company will appoint Brian Rosin as principal financial and accounting officer effective December 31, 2026, subject to approval by the board of directors and execution of an agreement formalizing the appointment. Rosin currently performs those functions for IM8 (US) LLC, Prenetics’ main operating subsidiary, as its chief financial officer.

Filing Explained

The report is incorporated by reference into Prenetics’ identified Form F-3 and Form S-8 registration statements from submission, unless later reports supersede it, making this personnel disclosure part of those registration statements.

Contribution period Eight years Period over which Prenetics described Stephen Hoi Chun Lo's contributions
principal financial and accounting officer technical
"as its principal financial and accounting officer"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
incorporated by reference regulatory
"This Report is incorporated by reference into the registration statements"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who will become PRE's principal financial and accounting officer?

The company will appoint Brian Rosin effective December 31, 2026, subject to board approval and execution of an agreement formalizing the appointment. Rosin currently serves as chief financial officer of IM8 (US) LLC, Prenetics Global Ltd's main operating subsidiary.

When does Stephen Hoi Chun Lo leave his CFO role at PRE?

Lo's resignation as chief financial officer is effective December 30, 2026. He tendered his resignation on October 30, 2026, and will continue to support the company in an advisory capacity after his departure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2026
 
Commission File Number 001-41401
 
 
Prenetics Global Limited
 
 
Unit 703-706, K11 Atelier
728 King’s Road, Quarry Bay
Hong Kong

(Address of principal executive office)
 

 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐
 

 
 






EXPLANATORY NOTE

On October 30, 2026, Stephen Hoi Chun Lo tendered his resignation as Chief Financial Officer of Prenetics Global Limited (the “Company”), effective December 30, 2026, to pursue new opportunities. Mr. Lo will continue to serve as Chief Financial Officer of the Company until that date. Following his departure, Mr. Lo will continue to support the Company in an advisory capacity. The Company is grateful to Mr. Lo for his dedication and valuable contributions over the past eight years and wishes him continued success in his future endeavors.

The Company will appoint Brian Rosin as its principal financial and accounting officer, effective December 31, 2026, subject to approval by the Company’s board of directors and execution of an agreement formalizing his appointment. Mr. Rosin currently performs the principal financial and accounting functions for IM8 (US) LLC, the Company’s main operating subsidiary, as Chief Financial Officer of IM8 (US) LLC.

The information contained in this Report on Form 6-K (this "Report"), furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing or in this report.


INCORPORATION BY REFERENCE

This Report is incorporated by reference into the registration statements on Form F-3 (File Nos. 333-265284, 333-276538 and 333-288824), and registration statements on Form S-8 (File Nos. 333-287017, 333-279019, 333-271552, 333-267956 and 333-298478) of Prenetics Global Limited (including any prospectuses forming a part of such registration statements), including all amendments thereto, filed with the U.S. Securities and Exchange Commission (the "SEC"), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Prenetics Global Limited
By:/s/ Danny Sheng Wu Yeung
Name:Danny Sheng Wu Yeung
Title:Chief Executive Officer
Date: November 2, 2026
 
 


Keep reading